Skip to main content
OpenTrials
Completed

NCT Number: NCT01796847

Relationship Between PTEN and Glycemic Variability and Outcome in Critically Ill Patients

Glycemic variability in critically ill patients is a recognized negative prognostic factor. The molecular mechanisms determining inter-patients variability in glucose metabolism during stress are not fully understood. The Phosphatase and Tensin homolog (PTEN) is known to influence glucose homeostasis by interfering in intracellular insulin signaling.

Aim of this study is to ascertain whether differential expression of PTEN in critically ill patients correlates with glycemic variability and clinical outcome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Rome La Sapienza, University Hospital

Rome, 00185, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • trauma
  • provision informed consent

Exclusion criteria

  • diabetes
  • impaired fasting glucose levels

Treatment and study plan

Primary outcomes

  1. Length of ICU stay

    Time frame: Day 1 up to day 28

Secondary outcomes

  1. Glycemic variability as expressed by standard deviation of the glycemia measurements

    Time frame: Day 1 up to day 28

Sponsors and collaborators

Lead sponsor

University of Roma La Sapienza

Other

Registry information

Official study title

Influence of PTEN on Glycemic Variability and Clinical Outcome in the Critically Ill Patient.

Acronym: GLUPTEN

Important dates

Study start
2012
Primary completion
2014
Study completion
2015
First posted
Feb 22, 2013
Registry last updated
Nov 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.